A Pilot Study to Explore the Role of Gut Flora in Eczema

Clinical Trial ID: NCT04214548

Description

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding eczema.

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to the information provided in surveys and in medical records regarding eczema.


Criteria

Inclusion Criteria: 1. Signed informed consent by patient 2. Male or female patients age 18 and older. 3. Diagnosis of eczema Exclusion Criteria: 1. Refusal by patient to sign informed consent form 2. Treatment with antibiotics within 2 weeks prior to screening 3. Treatment with probiotics within 6 weeks prior to screening 4. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy. 5. Postoperative stoma, ostomy, or ileoanal pouch 6. Participation in any experimental drug protocol within the past 12 weeks 7. Treatment with total parenteral nutrition 8. Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial 9. Inability of patient to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire stud

  • Start Date

    2020-03-02

  • Last Updated

    2020-03-04

  • Sponsor

    ProgenaBiome

  • Condition Name

    Eczema

Learn about this trial.

Check the eligibility requirements, study details, and more.

Related Trials

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.